Back
Avenue Therapeutics Stock Price Chart
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.
Sell
11
ATXI
Avenue Therapeutics
Last Price:
1.88
Seasonality Move:
15.12%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATXI is experiencing slight selling pressure.
Avenue Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.11 | Sell |
| 20-day SMA: | 2.18 | Sell |
| 50-day SMA: | 2.33 | Sell |
| 200-day SMA: | 5.44 | Sell |
| 8-day EMA: | 2.06 | Sell |
| 20-day EMA: | 2.16 | Sell |
| 50-day EMA: | 2.35 | Sell |
| 200-day EMA: | 12.99 | Sell |
Avenue Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 35.92 | Sell |
| Chaikin Money Flow: | -2212 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2 - 2.32) | Sell |
| Bollinger Bands (100): | (2.17 - 3.17) | Sell |
Avenue Therapeutics Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Avenue Therapeutics Stock
Is Avenue Therapeutics Stock a Buy?
- Avenue Therapeutics share price is 1.88 while ATXI 8-day simple moving average is 2.11, which is a Sell signal.
- The stock price of ATXI is 1.88 while Avenue Therapeutics 20-day SMA is 2.18, which makes it a Sell.
- Avenue Therapeutics 50-day simple moving average is 2.33 while ATXI share price is 1.88, making it a Sell technically.
- ATXI stock price is 1.88 and Avenue Therapeutics 200-day simple moving average is 5.44, creating a Sell signal.
ATXI Technical Analysis vs Fundamental Analysis
Sell
11
Avenue Therapeutics (ATXI)
is a Sell
Is Avenue Therapeutics a Buy or a Sell?
-
Avenue Therapeutics stock is rated a Sell
The current Avenue Therapeutics [ATXI] share price is $1.88. The Score for ATXI is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
Avenue Therapeutics Stock Info
Market Cap:
2.69M
Price in USD:
1.88
Share Volume:
13.96K
Avenue Therapeutics 52-Week Range
52-Week High:
26.47
52-Week Low:
1.70
Sell
11
Avenue Therapeutics (ATXI)
is a Sell
Avenue Therapeutics Share Price Forecast
-
What is the Avenue Therapeutics stock price today?
The Avenue Therapeutics stock price is 1.88 USD today. -
Will ATXI stock go up or go down?
Avenue Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Avenue Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Avenue Therapeutics is overvalued.
Is Avenue Therapeutics Stock a Buy?
- Avenue Therapeutics share price is 1.88 while ATXI 8-day exponential moving average is 2.06, which is a Sell signal.
- The stock price of ATXI is 1.88 while Avenue Therapeutics 20-day EMA is 2.16, which makes it a Sell.
- Avenue Therapeutics 50-day exponential moving average is 2.35 while ATXI share price is 1.88, making it a Sell technically.
- ATXI stock price is 1.88 and Avenue Therapeutics 200-day simple moving average is 12.99, creating a Sell signal.
Technical Analysis of Avenue Therapeutics
Should I short Avenue Therapeutics stock?
- ATXI Moving Average Covergence Divergence (MACD) indicator is -0.08, suggesting Avenue Therapeutics is a Sell
- Avenue Therapeutics Relative Strength Index (RSI) is 35.92, which suggest Avenue Therapeutics is oversold
- The Bollinger Bands (25) for Avenue Therapeutics is (2 - 2.32), which suggest Avenue Therapeutics is a Sell
- The Bollinger Bands (100) for Avenue Therapeutics is (2.17 - 3.17), which suggest Avenue Therapeutics is a Sell
* Avenue Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.